Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats
Article
[키워드] adipose
adjusted
Administered
alveolar
Anomaly
antiparasitic drug
assigned
Biochemistry
C max
changes in
Concentration
conducted
control group
COVID-19
detectable
dose
drug delivery
Drug development
Efficacy
enzyme
experiment
female
females
full blood count
groups
High-dose
histological
in vitro
Ivermectin
ivermectin dose
low-dose
lower dose
lung
lung tissue
male
nebulized
Particle
pharmacokinetic
plasma
plasma concentration
post intervention
Preclinical research
Randomly
RAT
reached
recent
reduction
required
respiratory diseases
RNA viruses
Safe
SARS-CoV-2 replication
Seven
subject
therapy
toxicology
was determined
[DOI] 10.1038/s41598-020-74084-y PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-020-74084-y PMC 바로가기 [Article Type] Article